SULFACETAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Sulfacetamide patents expire, and when can generic versions of Sulfacetamide launch?
Sulfacetamide is a drug marketed by Fougera Pharms, Padagis Us, Sun Pharma Canada, Alcon Pharms Ltd, Bausch And Lomb, Chartwell Rx, Epic Pharma Llc, Pharmafair, Pharmobedient, and Genus. and is included in twelve NDAs.
The generic ingredient in SULFACETAMIDE is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SULFACETAMIDE?
- What are the global sales for SULFACETAMIDE?
- What is Average Wholesale Price for SULFACETAMIDE?
Summary for SULFACETAMIDE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 12 |
| Drug Prices: | Drug price information for SULFACETAMIDE |
| DailyMed Link: | SULFACETAMIDE at DailyMed |



